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Vesicle aggregationGomesin (Gm) is an antimicrobial peptide ﬁrst isolated from the hemolymph of a Brazilian spider. Its powerful
antimicrobial activity is, however, accompanied by hemolysis. As an alternative to this issue, a linear analogue
(named GmL) lacking the disulﬁde bonds was designed. Here, CD spectroscopy, a ﬂuorescence-based leakage
assay, isothermal titration calorimetry (ITC) and light scattering are used to study the interaction of both Gm
and GmL with large unilamellar vesicles (LUVs) composed of POPC (palmitoyl oleoyl phosphatidylcholine)
with 25 and 50 mol% POPG (palmitoyl oleoyl phosphatidylglycerol). The activities of Gm and GmL in respect
to their binding afﬁnity/enthalpy, ability to permeabilize membranes and to induce vesicle aggregation are cor-
relatedwith peptide secondary structure. Whereas Gm displays a quite stable β-hairpinmotif irrespective of the
environment, GmL assumes a random conformation in aqueous solution and in the presence of 25 mol% POPG
but adopts a β-like structure in the presence of 50mol% POPG. Gm exhibited high lytic activity against both sur-
face charge densities. Instead, the activity of GmL was found to be negligible in the presence of 25 mol% POPG
LUVs, but comparable to that of the native peptide against 50mol% POPG as a consequence of peptide structuring.
We conclude that the activity of Gm and its linear analogue is intimately related to the formation of a β-turn
motif, in which the hydrophobic residues form a hydrophobic face able to insert into the membrane and disrupt
it.
© 2015 Elsevier B.V. All rights reserved.1. Introduction
Antimicrobial peptides aremolecules of the immune defense system
of animals and plants that play an important role in protection against
pathogenic agents, such as bacteria and fungi [1–4]. Their mode of ac-
tion generally depends on permeabilization and/or rupture of the cell
membrane of microorganisms. They generally exhibit a broad spectrum
of action, suggesting that the binding to targetmicrobial cells is notme-
diated by receptors [5]. Despite the structural diversity of these mole-
cules, they commonly exhibit an amphipathic character with a
positive net charge [6–9], features that are essential to allow them to
bind to themembrane ofmicroorganisms, which is rich in anionic lipids
[10–12]. Different lytic mechanisms have been proposed to elucidate
peptide-induced membrane permeabilization/rupture, such as the to-
roidal pore mechanism, in which peptides and lipids stabilize pores
across themembrane, and the carpet mode of action, in which peptides
cover themembrane ultimately leading to its disruption [13]. Addition-
ally, it has been proposed that some antimicrobial peptides might exert
their activity after formation of amyloid-like ﬁbers in the membrane[14,15]. Antimicrobial peptides have been largely studied because of
their potential use as a new class of antibiotics [16,17]. First isolated
from the innate immune system of different organisms [18], they can
be chemically synthesized and modiﬁed, aiming at the improvement
of their antimicrobial activity and reduction of hemolysis [19]. Since
the lytic mechanism of antimicrobial peptides generally rely on unspe-
ciﬁc interactions with membrane lipids, model membranes have been
widely used to unravel themechanisms underlying peptide/membrane
interactions [20–25].
Gomesin (Gm) is a powerful antimicrobial peptide present in hemo-
cytes of the Brazilian spider Acanthoscurria gomesiana. It consists of 18
amino acid residues (pGlu1-Cys-Arg-Arg-Leu5-Cys-Tyr-Lys-Gln-Arg10-
Cys-Val-Thr-Tyr-Cys15-Arg-Gly-Arg-NH2) with six positive charges.
Four cysteine residues (Cys2,15 and Cys6,11) confer to this peptide a β-
hairpin conformation in aqueous solution, as described by Mandard
et al. based onNMR studies [26]. Gmwasﬁrst isolated and characterized
in 2000 by Silva et al. in a pioneer study that demonstrated the Gm abil-
ity to kill bacteria and fungi with low minimum inhibitory concentra-
tions (MICs) [27]. Besides the antimicrobial activity, Gm was related to
apoptosis, inducing Ca2+ inﬂux in mammalian cells and in tumor cell
line CHO [28,29]. However, Gm also exhibits a relatively high hemolytic
activity. This hemolytic effect could be reduced or even abolished if spe-
ciﬁc modiﬁcations were done in the peptide structure. The removal of
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(termedhereafter GmL), resulted in a signiﬁcant decrease in the peptide
hemolytic activity [19,30]. Even though the MICs found for GmL were
higher than those of Gm, its therapeutic index (deﬁned for each patho-
gen as the ratio between peptide concentration that caused 10% hemo-
lysis and the peptide MIC) is better than that of Gm. Yet, this analogue
was rapidly degraded when incubated in human serum. Fázio et al.
[19,30] showed previously that Gm structure is not changed by the
solvent, whereas linear analogues can adopt secondary structures ac-
cording to the environment. Working with different analogues of Gm,
Moraes et al. [31] studied the interaction of these peptides with SDS
(sodium dodecyl sulfate) micelles and their antimicrobial activity. The
results emphasize the importance of the β-hairpin structure of Gm for
its biological activity.
In a previous study,we used opticalmicroscopy to study the interac-
tion of Gm and its linear analogue GmL with giant unilamellar vesicles
(GUVs) composed of palmitoyl-oleoylphosphatidylcholine (POPC) and
palmitoyl-oleoylphosphatidylglycerol (POPG), in different molar ratios
[32]. We showed that both Gm and GmL induce sudden burst of
GUVs, suggesting a carpet mode of action [33,34]. The activity of GmL
was found to be signiﬁcantly lower than that of Gm for low POPG
fraction, but becomes comparable to that of Gm for high POPG content.
In recent works, we studied the interaction of Gm and different ana-
logues that preserve the β-hairpin conformation with large unilamellar
vesicles (LUVs) composed of POPC and POPG using different ap-
proaches, namely isothermal titration calorimetry (ITC), leakage of a
ﬂuorescent probe entrapped in vesicles and light scattering measure-
ments [35,36]. ITC data showed that binding of Gm to anionic mem-
branes is an exothermic process that follows a stoichiometry of
roughly one gomesin charge per lipid charge. Light scattering data
show that Gm binding is always accompanied by peptide-induced
lipid aggregation [35]. This phenomenon is not exclusive for Gm, and
it was reported for other antimicrobial peptides [37,38]. Comparative
studies of the activity of Gm with analogues with different hydropho-
bic/hydrophilic balance and peptide charge showed that themagnitude
of the enthalpy change measured with ITC and the leakage percentage
induced are mainly governed by peptide hydrophobicity [36]. On the
other hand, peptide charge is decisive in deﬁning the extension of ag-
gregation. Gm and analogues containing a Trp residue were also able
to interact with SDS molecules [39].
In the present work, we perform a comprehensive study to compare
the activity of Gmwith that of its linear analogue GmL, which lacks the
disulﬁde bonds. LUVs composed of POPCwith 25 and 50mol% POPG are
used as model membranes to study the effect of membrane negative
charge on the activity of both peptides,whichhave the same six positive
charges. Circular dichroism, a leakage assay, ITC, light scattering and
zeta potential measurements are used to investigate the activity and
mode of action of Gm and GmL. These methods have been traditionally
used to study the interaction of model membranes with different anti-
microbial peptides [40–43]. We show that the activity of Gm is very
high against bothmembrane compositions explored,whereas the activ-
ity of GmL is strongly modulated by the fraction of POPG in the
membrane.2. Material and methods
2.1. Material
The lipids 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine
(POPC), 1-palmitoyl-2-oleoyl-sn-glycero-3-phospho-(1′-rac-glycerol)
(sodium salt) (POPG)were purchased fromAvanti Polar Lipids (Birming-
ham, AL). The ﬂuorescent probe 5(6)-carboxyﬂuorescein (CF), the deter-
gent Triton X-100, the buffer HEPES and NaCl were purchased from
Sigma-Aldrich (St. Louis, MN, USA). CF was puriﬁed before use as de-
scribed previously [44].2.2. Peptide synthesis, puriﬁcation and characterization
Gm and GmL were synthesized by the solid phase method [45],
using a MBAR (methylbenzhydrylamine) resin, and employing the
t-Boc strategy. After cleavage of the peptides from the resin, Gm
was submitted to a disulﬁde bond formation process monitored by liq-
uid chromatography coupled to a mass spectrometer, while GmL was
directly puriﬁed. The puriﬁcations of the peptides from lyophilized
crude solutionswere done by high performance liquid chromatography
(HPLC) in a C18 column. To guaranty high purity and to characterize
both peptides, HPLC coupled to a mass spectrometer (MS) was used.
Peptide purity was also assessed by amino acid analysis (AAA), per-
formed by ion-exchange chromatography on a Beckman 6300 amino
acid analyzer (Fullerton, CA). The results are listed in Table S1 in the
Supplementary material. At the end, the concentrations of Gm and
GmL were assessed by the optical density of the tyrosine and cystine
residues, when present, at λ= 280 nm [46].
2.3. Preparation of large unilamellar vesicles (LUVs)
A lipid ﬁlm of the desired composition (POPC with 25 or 50 mol%
POPG) was formed on the walls of a test tube from a lipid stock solution
in chloroform, dried with a stream of N2 and kept in a vacuum for 2 h.
The lipid ﬁlm was resuspended in a buffer solution (30 mM HEPES,
pH 7.4, containing 100 mMNaCl if not stated otherwise), and vortexed
to formmultilamellar vesicles (MLVs). This lipid dispersionwas extrud-
ed at least 11 times through a polycarbonatemembranewith a pore size
of 100 nm to yield LUVs.
For carboxyﬂuorescein (CF) leakage assay, LUVs were prepared in
30 mM HEPES, pH 7.4, containing 50 mM CF and 86 mM glucose. Glu-
cose was added to adjust the osmolarity of the solution. After the extru-
sion as described above, the lipid dispersion was ﬁltered through a
Sephadex resin G-25 medium column using 30 mM HEPES with
100 mM NaCl as eluting buffer to remove free CF. LUVs with entrapped
CF were collected from the void volume of the column.
To verify the phospholipid concentration at the end of the extrusion
process, a method based on the indirect determination of phosphorous
content was employed [47].
2.4. Circular dichroism (CD)
CD spectra were acquired using a Jasco spectropolarimeter (J-810,
Japan), in the range of 190–250 nm. The mixture of peptide (100 μM)
and lipid (500 μM) was placed in a circular quartz cuvette of 0.5 mm
light path. For the CD measurements, the samples were prepared in
10mMphosphate buffer, pH 7.4, since 30mMHEPES buffer and chloride
ions absorbs strongly at or below200 nm, interferingwith CD bands [48].
The acquisition parameters used were: 4 s response time, 50 nm/min
speed acquisition, 0.2 nm step in 4 accumulations. All experiments
were done at room temperature. The ﬁnal spectra, in millidegree (θ),
were expressed in units of residue molar ellipticity, [θ]MRW
(deg cm2 dmol−1), according to: [θ]MRW = (θ ∗ MRW) / (ℓ ∗ c ∗ 10),
where MRW is the mean residue weight (protein mean weight/number
of residues), ℓ is the optical length (cm) and c is the peptide concentra-
tion (mg/mL).
2.5. Carboxyﬂuorescein (CF) leakage assay
CF leakage experiments were performed in a Hitachi spectroﬂuo-
rometer (F-2500, Washington, DC). A quartz cuvette of 1 cm light
pathwasﬁlledwith 0.5mLof a suspension of LUVs (50 μMlipid concen-
tration) containing 50mMCF entrapped (CF-LUVs), as described above.
The CF ﬂuorescence was monitored at λ= 520 nm, using λ= 490 nm
as excitation wavelength. Different concentrations of peptides (0.05–
10 μM)were added to CF-LUV suspension. At the end of the experiment
(~55 min), 10 μL of Triton X-100 at 10% (w/v) were added to promote
Fig. 1. Circular dichroism spectra of 100 μM Gm and GmL in buffer (dotted lines), and in
the presence of LUVs of POPC with 25 (dashed lines) and 50 mol% POPG (solid lines)
(500 μM lipid concentration).
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using the following equation: %Leakage = 100(Ft− F0) / (Fmax− F0),
where F0 is the CFﬂuorescence before peptide addition, Ft is the CF ﬂuo-
rescence at the chosen time, and Fmax is the CF ﬂuorescence after deter-
gent addition [35].
2.6. Isothermal titration calorimetry (ITC)
A microcalorimeter VP-ITC from Microcal (Northampton, MA) was
used to assess the thermodynamic parameters of lipid–peptide interac-
tion. For this, the calorimeter cell (1.4576 mL) was ﬁlled with the pep-
tide solution, and the syringe was loaded with a dispersion of LUVs.
Lipid aliquots of 5 μL were injected into the peptide solution every
10min. A ﬁrst 0.5 μL injection was alwaysmade to reduce the volumet-
ric error of the syringe plunger and discarded from the analysis. The
temperature was set to 25 °C.
2.7. Static light scattering
Measurements of 90° static light scattering were done in a Hitachi
spectroﬂuorometer (F-2500) in the same conditions as the ITC experi-
ments. A peptide solution was placed in a quartz cuvette of 1 cm light
path (1.5 mL), and sequential 5 μL injections of LUVs from a stock solu-
tion were done every 10 min. All experiments were performed at room
temperature and under magnetic stirring.
2.8. Zeta potential and dynamic light scattering
Dynamic light scattering (DLS) and electrophoretic mobility (using
laser Doppler velocimetry) measurements were performed with a
Zetasizer Nano ZS (Malvern, UK). Both measurements were done after
sequential injections from a 300 μM peptide stock solution in a cuvette
containing LUVs at 0.1 mM lipid concentration. For these measure-
ments, 100 mM NaF was used instead of NaCl to reduce oxidation of
the electrodes, since the ﬂuoride redox potential is higher than that of
chloride and hardly reached by the voltage potential applied by the
equipment. The DLS data are given as the Z-average particle size as a
function of the peptide-to-lipid molar ratio. Zeta potential, ζ, was calcu-
lated from the measured electrophoretic mobility (μ) using the Henry
equation: ζ ¼ 3ημ2ε fðκaÞ, where ε is the dielectric constant and η the water
viscosity; f(ka) in this case is 1.5, referring to the Smoluchowski
approximation.
3. Results and discussion
The interaction of the antimicrobial peptide gomesin (Gm) and its
linear analogue [Ser2,6,11,15]-Gm (GmL) with negatively charged LUVs
was studied with different experimental approaches. The LUVs were
composed of POPC containing either 25 or 50 mol% POPG to explore
the role ofmembrane negative charge in the activity of the cationic pep-
tides. In the following, the results obtainedwith each technique are pre-
sented separately.
3.1. CD measurements
The conformation of Gm and GmL was evaluated by circular dichro-
ism (CD) both in buffer solution and in the presence of LUVs at a 0.2
peptide-to-lipid (P/L) molar ratio. This high P/L was chosen since both
peptide and lipid concentrations have a strict range of variation: at
lower peptide concentrations the CD signal is very weak or absent,
and at higher lipid concentrations the CD signal is noisy, due to in-
creased sample turbidity. The CD spectra are shown in Fig. 1. The CD
spectra of Gm in buffer and in the presence of LUVs (curves in black)
are characteristic of a β-hairpin structure, as previously described byMandard et al. using the NMR technique [26]. A small red shift in the
negative band (~2 nm) is observed in the presence of 50 mol% POPG.
The linear analogueGmL,which lacks the disulﬁde bonds that confer
the β-hairpin structure to Gm, showed spectrum features of a random
motif with a negative band at ~198 nm in buffer solution (red dotted
line in Fig. 1), as expected [19]. The conformation of GmL is almost un-
altered in the presence of LUVs composed of 25mol% POPG (red dashed
line). However, by increasing the POPG content of the LUVs to 50 mol%,
the CD spectrum (red straight line) of GmL acquires two new bands: a
positive at ~211 nm and a negative at ~223 nm. The last negative
band is present in peptides that adopt a β-turn motif, with the positive
band around 205 nm [49]. When the content of POPGwas increased up
to 100 mol% (Fig. S1), the negative band around 223 nm became more
evident, and the positive band was shifted to ~197 nm, corresponding
to a well-deﬁned turn II spectrum, while Gm adopts a turn I motif
[49]. Even though the CD spectra of GmL in the presence of LUVs are dif-
ferent from those of Gm, they display feature characteristic of β-
structures. This shows that GmL has a tendency to adopt β-structures
instead of α-helix in the presence of negatively charged bilayers. The
percentages of secondary structures obtained from data ﬁts are shown
in the Supplementary material (Table S2).
3.2. CF leakage assay
The ability of Gm and GmL to permeabilize membranes was moni-
tored by the leakage of the ﬂuorescent probe CF, initially entrapped in
LUVs in high concentration (50 mM) with self-quenched ﬂuorescence.
Peptide-induced leakage is detected as an increase in the ﬂuorescence
intensity, which can be directly related to the percentage of CF leakage
(Section 2.5).
CF leakage kinetics induced by Gm and GmL in LUVs of 25 and
50mol% POPGwere obtained at ﬁve different peptide-to-lipidmolar ra-
tios in the range 0.001–0.2 P/L. All curves obtained are shown in the
Supplementarymaterial (Fig. S3) and the ones for the highest P/L tested
are shown in Fig. 2A. The CF leakage induced by both Gm and GmL in
50 mol% POPG occurs very fast and reaches almost full leakage within
a few seconds. The native peptide also induces high leakage percentage
in 25 mol% POPG, but at a much slower rate. This difference in kinetic
mechanism was observed for all P/L ratios tested (see Fig. S3). Instead,
only a mild leakage is induced by the linear analogue in 25 mol% POPG.
Fig. 2B shows the percentage of CF leakage reached at the end of the
experiment (~55 min) as a function of P/L. For most conditions, this
time was enough to reach a roughly constant maximal leakage value.
Fig. 2. CF leakage from LUVs. A)Kinetics of the percentage of CF leakage fromLUVs of POPC
with 25 (open symbols and dashed lines) and 50 mol% POPG (solid symbols and solid
lines) in the presence of Gm (black) and GmL (red) at 0.2 P/L molar ratio. Addition of
the peptide occurred after 3 min and a concentrated aliquot of Triton X-100 was added
close to the end of the experiment (~55 min) to induce full leakage. B) Percentage of CF
leakage at ~55 min as a function of the peptide-to-lipid molar ratio. The percentage of
leakage was calculated based on the equation described in Material and methods.
Fig. 3. ITC data obtained from the titration of Gm (black) and GmL (red) with LUVs com-
posed of POPC with 25 (open symbols) and 50 mol% POPG (solid symbols). The experi-
mental data is represented by symbols, showing A) the integrated heat per mole of
injectant, δh, as a function of the lipid-to-peptidemolar ratio, and B) the binding isotherms
(extent of binding Xb as a function of the concentration of free peptide Cfree). The lines
refer to the best ﬁt obtained with the surface partition model combined with the Gouy–
Chapman theory (the ﬁt parameters are listed in Table 1). Peptide concentration in cell
was 10 μM (25 mol% POPG) and 15 μM (50 mol% POPG) Gm, and 20 μM GmL. The lipid
concentration usedwas 10 (25mol% POPG) and 6mM (50mol% POPG). The injection vol-
ume usedwas 5 μL. Buffer: HEPES 30mMwith 100mMNaCl, pH7.4. The temperaturewas
25 °C.
Table 1
Thermodynamic parameters obtained from ITC experiments of Gm and GmL with 25 and
50 mol% POPG LUVs.
ΔH
(kcal/mol)
K
(M−1)
TΔS
(kcal/mol)
25 mol% POPG
Gm −5.6 1 × 104 +2.2
GmL 0 –
50 mol% POPG
Gm −7.0 5 × 105 +3.1
GmL −9.4 1 × 105 −0.2
ΔH is the reaction heat per mole of peptide and K is the intrinsic binding constant in the
surface partition model combined with the Gouy–Chapman theory. The effective charge
of the peptideswas+5.5. The entropic contribution, TΔS,was calculated from the thermo-
dynamic relations ΔG= ΔH− TΔS and ΔG=−RT ln (55.5 K), where the term 55.5 cor-
rects the unit of K to molar fraction.
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sitions tested, reaching almost complete leakage at the highest P/L. Sim-
ilar behavior was observed for the activity of GmL against 50 mol%
POPG. On the other hand, GmL induced low CF leakage from LUVs of
25 mol% POPG.
3.3. Isothermal titration calorimetry (ITC)
ITC experiments were performed as a titration of the peptide solu-
tion with LUVs. The heat ﬂow curves as a function of time and the
heat per mole of injectant, δh, obtained from the integration of each
peak, are shown in the Supplementary material (Fig. S4). Fig. 3A
shows δh as a function of the lipid-to-peptide molar ratio (L/P) for all
conditions explored. The interaction of Gmwith charged LUVs is mainly
an exothermic process, with and inﬂection point corresponding roughly
to 6 PG/Gm, i.e., one negative lipid charge per positive charge of Gm. The
same trend is detected in the interaction of GmL with 50 mol% POPG.
However, no detectable interaction was found between the linear ana-
logue and 25mol% POPG. The totalΔH of the process (obtained by sum-
ming the δh along the titration and dividing by the number of moles of
peptides in the calorimeter cell) is shown in Table 1.Fig. 3B shows the binding isotherms (extent of peptide binding per
mole of lipid, Xb, as a function of the concentration of free peptide avail-
able, Cfree) calculated from the ITC data (see ref. [36] for details). In the
Fig. 4. 90° light scattering measurements (λ= 600 nm) obtained from lipid injections
(5 μL) into a peptide solution. The L/P ratio of each injection corresponds to those of the
ITC experiment (Fig. 3) for each condition. A) Titration of 10 μM Gm (black lines) and
20 μM GmL (red lines) with LUVs of POPC with 25 mol% POPG (10 mM), and B) titration
of 15 μM Gm (black lines) and 20 μM GmL (red lines) with LUVs of POPC with 50 mol%
POPG (6mM). The buffer titration with LUVs for both conditions is presented as a dashed
line (black) in each graph.
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themaximum extent of peptide binding per lipid (in excess of peptide).
If these values are given with respect to POPG only (see Fig. S5 in the
Supplementary material), the following Pbound/POPG values are obtain-
ed: 0.20, 0.19 and 0.18, representing again almost one lipid charge per
peptide charge. The binding isotherms obtained for each system exhibit
different details, but the overall trend is the same and ismainly dictated
by a charge–charge interaction.
The ITC data were ﬁt with a surface partition model combined with
the Gouy–Chapman theory, as described in detail elsewhere [35,41,50].
This model describes the membrane/water partition of cationic pep-
tides at charged interfaces taking into account the Boltzmann distribu-
tion created by the membrane surface potential. The ﬁts were done
using the experimental value of ΔH and ﬁxing the effective charge of
Gm and GmL to z=+5.5, very close to the nominal charge of both pep-
tides. The total lipid concentration was taken into account, since from
leakage experiments (Fig. 2), almost complete leakage is detected in
the L/P range along the titration curve, implying that all lipids are avail-
able for binding. The only free parameter left was the intrinsic binding
constant, K. The best ﬁts obtained with this model are shown as lines
in Fig. 3 and the corresponding thermodynamic parameters obtained
are shown in Table 1. The binding constant K and ΔH of Gm are higher
for the more charged surface. The fact that these parameters are sensi-
tive to the membrane charge density shows that the model used is
not perfect in describing peptide–lipid interaction. Nevertheless, we
can still conclude that Gm and structured GmL interact with anionic
lipids mainly in a one-to-one charge fashion and in an enthalpy-
driven process which can be associated with a non-classical hydropho-
bic effect upon insertion of the hydrophobic face into the membrane
[36,50].
The interaction parameters obtained for Gm and GmL with 50 mol%
POPG are similar, but the enthalpy change of GmL is higher than that of
Gm. This higher ΔH can be partially explained by the structuring of
GmL upon binding to the membrane surface. Considering that one GmL
molecule could make up to ﬁve H-bonds, according to the structure
adopted by native Gm [26], and that each H-bond contributes with
ΔH ~ 0.3 kcal/mol [51,52], the change in GmL conformation from
disordered to β-turn could account for an additional ΔH in the range of
1.5 kcal/mol. An entropic contribution was detected only for the binding
of Gm, which is probably associated with the loss of hydration water
molecules as the peptide binds to and inserts its hydrophobic region
into the membrane. This contribution in the linear analogue is probably
compensated by the peptide structuring at the membrane interface.
3.4. Light scattering measurements
Static and dynamic light scattering assays were done to monitor the
lipid aggregation promoted by Gm and GmL. Static light scatteringmea-
surements (Fig. 4) were set to reproduce the same experimental condi-
tions as those of the ITC experiments (Fig. 3). The dotted lines in black
refer to the light scattering intensity obtained from lipid injection into
a buffer solution, forwhich a constant value dependent on the lipid con-
centration is obtained. Injections of LUVs into a peptide solution show a
quite different outcome, depending on membrane charge and the pep-
tide. Mild aggregation is detected as an increased light scattering, as ob-
served for the titration of GmLwith LUVs of 25mol% POPG (Fig. 4A, red).
Whenmicrometer-sized aggregates are formed, light scattering initially
increases sharply and then decreases due to precipitation of the aggre-
gates (see e.g. black curves in Fig. 4A). This effect is even stronger for in-
jections of 50mol% POPG LUVs into Gm or GmL (Fig. 4B). The extensive
aggregation pattern is detected for the same injections that give rise to
exothermic signals in the ITC experiment (see Fig. 3). After that, con-
stant light scattering with time is observed, showing that no further ag-
gregation occur.
Dynamic light scattering (DLS) data were acquired by titration of a
dispersion of LUVs with peptide. The titration was performed in areverse way as compared with ITC and static light scattering measure-
ments to monitor the effect of the peptides on the initial size and zeta
potential (next section) of LUVs. Fig. 5 shows the Z-average size obtain-
ed when LUVs were titrated with Gm and GmL. The sizes of the LUVs of
25mol% POPG remain roughly constant at their original size (~100 nm)
during the titrationwith GmL. In all other cases, a signiﬁcant increase in
size up tomicrometers is observed. DLSmeasurements are not accurate
for such large size aggregates, resulting in large ﬂuctuations in the Z-
average values at high P/L molar ratios. The onset of aggregation de-
pends mainly onmembrane composition and is consistent with the dif-
ferent stoichiometry detected in the ITC experiment. Micrometer-sized
aggregates are also reached around 6 PG/peptide.
The light scattering results show that binding of bothGmandGmL to
charged LUVs is always accompanied by lipid aggregation. The extent of
aggregation is highly enhanced by membrane charge and correlates
with peptide binding/afﬁnity. Since Gm has its six positive charges dis-
tributed around theβ-hairpin structure [26], it becomes easier for Gm to
interact with adjacent LUVs [36]. On the other hand, the ability of the
linear analogue GmL to induce aggregation depends on its acquiring a
secondary structure similar to that of Gm. The peptide–lipid aggregates
proposed to be formed are depicted as amodel in ref. [23], with the pep-
tides linking adjacent bilayers or even creating bulk phase patches in
which a bilayer structure no longer exists.
Fig. 5. Dynamic light scattering of Gm (data in black) and GmL (data in red) interacting
with LUVs composed of POPC with 25 (dashed lines and open symbols) and 50 mol%
POPG (solid lines and solid symbols). The Z-average of particles (μm) is presented as a
function of the peptide-to-lipid molar ratio.
Fig. 6. Zeta potential (ζ) measurements for Gm (black) and GmL (red) interacting with
LUVs composed of POPCwith A) 25 (open symbols) and B) 50mol% POPG (solid symbols)
as a function of the peptide-to-lipid molar ratio. The dashed lines indicate the P/L molar
ratio above which micrometer-sized aggregates were detected with DLS (Fig. 5) per-
formed on the same sample.
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Zeta potential was calculated from electrophoretic mobility mea-
surements (Section 2.8) along the titration of LUVs with Gm and GmL,
in the same titration experiment in which the DLS results were obtain-
ed. The results are shown in Fig. 6. The initial value, at P/L = 0, was ob-
tained in the absence of peptide. The zeta potential becomes less
negativewith the addition of peptides, indicating binding of the cationic
peptides to the anionic membrane surface. Complete charge neutraliza-
tion is seen only for Gmwith 50mol% POPG above 0.1 P/L. Charge rever-
sal would not be expected since from the ITC binding curves (see
Fig. 3B) the maximum peptide bound per mole of lipid is slightly
lower than complete charge neutralization. However, it should be
stressed that micrometer-sized aggregates are formed and precipitate
in all conditions except for 25 mol% POPG in the presence of GmL (see
Figs. 4 and 5). The dashed lines in Fig. 6 indicate the P/L above which
micrometer-sized aggregates were detected with DLS. Up to that
point, the data can be trusted and show a similar trend as observed
with the other techniques. The zeta potential is only slightly affected
by the addition of GmL to 25 mol% POPG, whereas it becomes signiﬁ-
cantly less negative upon the addition of GmL to 50 mol% POPG and of
Gm to both membrane compositions. Above the P/L ratio indicated
with the dashed lines, the data obtained from addition of Gm and
GmL to 50 mol% POPG diverge signiﬁcantly, probably an artifact due
to the extent of aggregation.4. Conclusions
The interaction of the antimicrobial peptide Gm and its linear ana-
logue GmL with charged LUVs was assessed with complementary ap-
proaches to provide a comprehensive picture of the mechanism of
action of Gm focusing the role of peptide secondary structure andmem-
brane charge. Peptide activity was correlated with its ability to bind to
and permeabilize membranes and to induce vesicle aggregation. In a
general view, all techniques showed that the activity of Gm is much
higher than that of GmL at low membrane surface charge (25 mol%
POPG), but their activities become practically the same at high POPG
content (50 mol% POPG). These results agree well with our previous
work with giant unilamellar vesicles (GUVs) in the presence of Gm
and GmL [32].In the conditions explored in the present study, the conformations
adopted by Gm and GmL at the membrane interface, as assessed by
CD data, are directly related to peptide activity. Gm,which due to the di-
sulﬁde bonds adopts a quite stable β-hairpin structure irrespective of
the environment, exhibited high activity toward 25 and 50 mol%
POPG. On the other hand, the activity of the linear analogue GmL was
strongly modulated by membrane surface charge. LUVs containing
25 mol% POPG, with a low density of negative charges, would favor a
more relaxed conformation of GmL. At higher POPG density, GmL
adopts a β-turn conformation in which the hydrophobic residues
(Leu5, Tyr7, Val12 and Tyr14) form an apolar face able to insert into and
perturb the membrane, in a similar way as Gm [26,36]. Fig. 7 shows
structures of Gm and GmL consistent with their CD spectra in different
environments (see Supplementary material for further details). GmL
adopts the active conformation in the presence of highly chargedmem-
branes. Taking into account that the membrane of some microorgan-
isms exhibits a high fraction of charged lipids, a linear version of Gm
could show a promising therapeutic window combining low hemolysis
with high antimicrobial activity against such pathogens.Transparency document
The Transparency Document associated with this article can be
found, in the online verison.
Fig. 7. Structures of Gm and GmL drawn with the program YASARA view [53] from PDB
structures. The backbones are shown in blue and the hydrophobic residues (Leu5, Tyr7,
Val12 and Tyr14) are colored with red. The conformations of GmL were obtained from
structure predictions using the online software I-TASSER [54–56]. The theoretical CD spec-
tra of these structures are shown in Fig. S3 and are similar to the experimental spectra of
GmL in buffer (inactive) and in the presence of 75 mol% POPG (active). The structure of
Gm (ID: 1kfp, [57]) corresponds to the one reported by Mandard et al. [26]. The dotted
lines represent the disulﬁde bonds.
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